Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management

Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management

Introduction: Timely access to quality biomarker testing in NSCLC is critical to patient outcomes. The Canadian Pathology Quality Assurance provides external quality assurance (EQA) to laboratories in Canada. The Canadian Pathology Quality Assurance has recently developed a novel approach to molecul...

Full description

Saved in:
Bibliographic Details
Main Authors: Kassandra R. Bisson, MHSc, Andrea Beharry, MLT, Normand Blais, MD, Michael D. Carter, MD, PhD, Parneet K. Cheema, MD, Patrice Desmeules, MD, John G. Garratt, RT, Barbara Melosky, MD, Bryan Lo, PhD, Stephanie Snow, MD, Basile Tessier-Cloutier, MD, Edwin Tio, MD, Stephen Yip, MD, PhD, Jennifer R. Won, PhD, Brandon S. Sheffield, MD
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:JTO Clinical and Research Reports
Subjects:
Proficiency testing
Precision oncology
NSCLC
Biomarkers
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364325000530
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666364325000530

Similar Items